XML 54 R16.htm IDEA: XBRL DOCUMENT  v2.3.0.11
11. Segment Reporting
 6 Months Ended
Jun. 30, 2011
Segment Reporting [Abstract]  
Segment Information
SEGMENT INFORMATION


Information regarding industry segments for the three months ended June 30, 2011 and 2010 is as follows (in millions):


 
 
Life
Science
 
Clinical
Diagnostics
 
Other
Operations
 
 
 
 
 
 
 
Segment net sales 
2011
$
169.9


 
$
348.0


 
$
3.7


 
2010
$
150.7


 
$
314.1


 
$
2.9


 
 
 
 
 
 
 
Segment profit
2011
$
10.0


 
$
46.6


 
$
0.5


 
2010
$
7.7


 
$
46.8


 
$
0.2




Information regarding industry segments for the six months ended June 30, 2011 and 2010 is as follows (in millions):


 
 
Life
Science
 
Clinical
Diagnostics
 
Other
Operations
 
 
 
 
 
 
 
Segment net sales 
2011
$
324.4


 
$
675.2


 
$
7.2


 
2010
$
302.0


 
$
613.9


 
$
6.0


 
 
 
 
 
 
 
Segment profit
2011
$
13.1


 
$
94.6


 
$
0.7


 
2010
$
19.1


 
$
85.1


 
$
0.1








Segment results are presented in the same manner as we present our operations internally to make operating decisions and assess performance.  Net corporate operating expense consists of receipts and expenditures that are not the primary responsibility of segment operating management.  Interest expense is charged to segments based on the carrying amount of inventory and receivables employed by that segment.  The following reconciles total segment profit to consolidated income before taxes (in millions):
 
Three Months Ended
 
Six Months Ended
 
June 30,
 
June 30,
 
2011
 
2010
 
2011
 
2010
Total segment profit
$
57.1


 
$
54.7


 
$
108.4


 
$
104.3


Foreign exchange losses, net
(2.7
)
 
(1.0
)
 
(5.8
)
 
(0.8
)
Net corporate operating, interest and other expense not allocated to segments
(1.0
)
 
(0.8
)
 
(1.9
)
 
(1.6
)
Other income (expense), net
4.4


 
2.5


 
5.4


 
3.3


Consolidated income before taxes
$
57.8


 
$
55.4


 
$
106.1


 
$
105.2